Drew J. Winston
Distinguished in Cytomegalovirus Infection

Dr. Drew J. Winston

Infectious Disease
10833 Leconte Ave, Ucha Medical Center Dept Of Medicine Room 42 121 Chs, 
Los Angeles, CA 
50 Years of Experience
Distinguished in Cytomegalovirus Infection
10833 Leconte Ave, Ucha Medical Center Dept Of Medicine Room 42 121 Chs, 
Los Angeles, CA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Drew Winston is an Infectious Disease provider in Los Angeles, California. Dr. Winston has been practicing medicine for over 50 years and is rated as a Distinguished provider by MediFind in the treatment of Cytomegalovirus Infection. His top areas of expertise are Cytomegalovirus Infection, Shingles, Cytomegalic Inclusion Disease, and Chickenpox.

His clinical research consists of co-authoring 39 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 12 articles in the study of Cytomegalovirus Infection.

Specialties
Infectious Disease
Licenses
Internal Medicine in CA
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO

Locations

10833 Leconte Ave, Ucha Medical Center Dept Of Medicine Room 42 121 Chs, Los Angeles, CA 90024

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Phase 3, Multicenter, Randomized, Double-blind, Double-dummy, Active-controlled Study to Assess the Efficacy and Safety of Maribavir Compared to Valganciclovir for the Treatment of Cytomegalovirus (CMV) Infection in Hematopoietic Stem Cell Transplant Recipients
A Phase 3, Multicenter, Randomized, Double-blind, Double-dummy, Active-controlled Study to Assess the Efficacy and Safety of Maribavir Compared to Valganciclovir for the Treatment of Cytomegalovirus (CMV) Infection in Hematopoietic Stem Cell Transplant Recipients
Enrollment Status: Completed
Publish Date: March 03, 2023
Intervention Type: Drug, Other
Study Phase: Phase 3
An Intermediate-size, Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease
An Intermediate-size, Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease
Enrollment Status: No_longer_available
Publish Date: March 14, 2022
Intervention Type: Drug
A Phase 3, Multicenter, Randomized, Open-label, Active-controlled Study to Assess the Efficacy and Safety of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment With Ganciclovir, Valganciclovir, Foscarnet, or Cidofovir
A Phase 3, Multicenter, Randomized, Open-label, Active-controlled Study to Assess the Efficacy and Safety of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment With Ganciclovir, Valganciclovir, Foscarnet, or Cidofovir
Enrollment Status: Completed
Publish Date: November 03, 2021
Intervention Type: Drug
Study Phase: Phase 3
Prophylaxis Versus Preemptive Therapy for the Prevention of CMV in High-Risk R-D+ Liver Transplant Recipients
Prophylaxis Versus Preemptive Therapy for the Prevention of CMV in High-Risk R-D+ Liver Transplant Recipients
Enrollment Status: Completed
Publish Date: August 26, 2021
Intervention Type: Drug
Study Phase: Phase 4
A Randomized, Controlled, Open-Label, Multiple Ascending Dose Study of Intravenous Brincidofovir in Adult Allogeneic Hematopoietic Cell Transplant Recipients With Adenovirus Viremia
A Randomized, Controlled, Open-Label, Multiple Ascending Dose Study of Intravenous Brincidofovir in Adult Allogeneic Hematopoietic Cell Transplant Recipients With Adenovirus Viremia
Enrollment Status: Withdrawn
Publish Date: July 21, 2021
Intervention Type: Drug
Study Phase: Phase 2
A Prospective Observational Study for the Long-term Follow-up of Subjects Previously Enrolled in Selected Clinical Studies of CMX001.
A Prospective Observational Study for the Long-term Follow-up of Subjects Previously Enrolled in Selected Clinical Studies of CMX001.
Enrollment Status: Terminated
Publish Date: May 17, 2019
Intervention Type: Drug
View 5 Less Clinical Trials

39 Total Publications

Real-world clinical impact of plasma cell-free DNA metagenomic next-generation sequencing assay.
Real-world clinical impact of plasma cell-free DNA metagenomic next-generation sequencing assay.
Journal: Infection control and hospital epidemiology
Published: January 30, 2025
Similar Doctors
Distinguished in Cytomegalovirus Infection
Dr. Sanjeet S. Dadwal
Infectious Disease
Distinguished in Cytomegalovirus Infection
Dr. Sanjeet S. Dadwal
Infectious Disease

City Of Hope Medical Foundation

209 Fair Oaks Ave, 
South Pasadena, CA 
 (17.2 miles away)
626-396-2900
Languages Spoken:
English

Sanjeet Dadwal is an Infectious Disease provider in South Pasadena, California. Dr. Dadwal is rated as a Distinguished provider by MediFind in the treatment of Cytomegalovirus Infection. His top areas of expertise are Cytomegalovirus Infection, Sepsis, Cytomegalic Inclusion Disease, and Chronic Graft Versus Host Disease (cGvHD).

Distinguished in Cytomegalovirus Infection
Dr. Joanna M. Schaenman
Infectious Disease
Distinguished in Cytomegalovirus Infection
Dr. Joanna M. Schaenman
Infectious Disease

The Regents Of The University Of California

200 Ucla Medical Plz, Suite 165 34, 
Los Angeles, CA 
 (0.2 miles away)
310-824-8403
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Joanna Schaenman is an Infectious Disease provider in Los Angeles, California. Dr. Schaenman is rated as a Distinguished provider by MediFind in the treatment of Cytomegalovirus Infection. Her top areas of expertise are Cytomegalovirus Infection, Cytomegalic Inclusion Disease, COVID-19, and Cryptococcosis.

Advanced in Cytomegalovirus Infection
Dr. Ashrit Multani
Infectious Disease
Advanced in Cytomegalovirus Infection
Dr. Ashrit Multani
Infectious Disease

The Regents Of The University Of California

900 Weyburn Place, Suite 14 171, 
Los Angeles, CA 
 (0.5 miles away)
310-825-8173
Experience:
16+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Ashrit Multani is an Infectious Disease provider in Los Angeles, California. Dr. Multani has been practicing medicine for over 16 years and is rated as an Advanced provider by MediFind in the treatment of Cytomegalovirus Infection. His top areas of expertise are Cytomegalovirus Infection, Chagas Disease, Cytomegalic Inclusion Disease, and Strongyloidiasis.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Winston's expertise for a condition
ConditionClose
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile